Loading

JSM Clinical Case Reports

Poisoning with Juniperus oxycedrus (Cade Oil): About a Case at the A4 Intensive Care Unit of the HASSAN II University Hospital in Fez

Case Report | Open Access | Volume 12 | Issue 2

  • 1. Unit of Toxicology, University Hospital Hassan II, Fez, Morocco
+ Show More - Show Less
Corresponding Authors
Acher Mugisha, Unit of Toxicology, University Hospital Hassan II, Fez, Morocco
Abstract

Cade oil is a product extracted from the branches and wood of Juniperus oxycedrus. It contains etheric oils, triterpene and phenols.

Used widely in traditional Moroccan medicine with a high frequency of serious poisoning, especially in young children. We report here the case of an elderly subject victim of ingestion of cade oil, admitted in a state of neurological, renal and hepatic instability, successfully placed under resuscitation measures.

Citation

Mugisha A, Salaheddine S, Naoufil H, Nabil K (2024) Childhood Poisoning with Juniperus oxycedrus (Cade Oil): About a Case at the A4 Intensive Care Unit of the HASSAN II University Hospital in Fez. JSM Clin Case Rep 12(2): 1240.

INTRODUCTION

Cade oil (Guetran) often used by “Ferraga” can cause serious or even fatal accidents [1].

This oil obtained by dry distillation from branches of Juniperus oxycedrus (Mediterranean species) is used locally for skin conditions (psoriasis and eczema) and as an antiparasitic and antiseptic.

Poisoning is most often of iatrogenic origin, resulting from ingestion of a large quantity or prolonged and extensive skin application, especially in infants and newborns [2].

It contains etheric oils, triterpene and phenols. Phenol remains the most toxic component and probably responsible for the majority of systemic symptoms observed during poisoning [3].

After ingestion of cade oil by a subject, they may then present a clinical picture due to the “mixture” between the underlying pathology for which they are taking it, and the picture of intoxication or infection.

Description and chemical composition

Cade oil is a thick and homogeneous liquid, black in color and with a particular strong and empyreumatic odor.

Cade oil dissolves completely in different organic solvents (ether, crystalline acetic acid, benzene, chloroform, etc.).

It contains 17 to 26% phenols, including 12% guaiacol, cadinene, and other carbides, an alcohol, cadinol. Its antiseptic and antiparasitic properties are universally known and attributed to phenols [4].

What are the properties of cade oil?

Cade oil is considered to be:

• Antibacterial and digestive antiseptic: cade oil can stop the development of certain bacteria responsible for itchy skin;

• Anti-inflammatory: it calms rashes and reactions of the skin;

• Healing: cade oil can be found in many creams, soaps or shower gels intended for sensitive skin;

• Repellent, due to its smell, cade oil helps keep away summer insects but also those living around horses and sheep;

• Relaxing.

Its field of application was wide because it could be prescribed for the treatment of pulmonary diseases as well as for dental pain or certain eye diseases. It was also used internally, as part of the treatment of cholelithiasis, chronic nephritis but especially as an antihelmintic, in children who had a verminous condition [5-7].

CASE REPRESENTATION

Clinical observation

Identify: This is a 64-year-old patient, originally from and living in Fez.

Medical background

• Concept of psychosis put under treatment in 2015 with poor compliance (mystical theme, hypochondriac according to relatives) ·

• Chronic smoker says he quit more than 3 years ago ·

• Concept of consumption of plants and herbs for therapeutic purposes

• No concept of hypertension or underlying diabetes

• No known nephropathy

The history of the illness dates back to 4 days before his admission where the patient took cade oil in a context of acute diarrhea, the patient had consulted a “traditional healer” who applied cade oil on the neck, torso and back of the patient without any immediate skin reactions being reported. The patient was also asked to ingest 3 large spoons of cade oil daily. The clinical picture was complicated by the onset of vigilance disorders, as well as abnormal bilateral movements, motivating his loved ones to consult the emergency room of the Fes University Hospital Center.

Note that the family found a 50ml bottle near the patient with half consumed?

Physical examination: Vital parameters: HR: 88 bpm FR: 20cycle/min BP 16/10cm Temperature: 36.9°C, Dextro at 3g/dl

Performing an EKG: without anomalies

Anti-poison center contacted: monitoring of respiratory, neurological, hepatic and renal failures with carrying out a troponin.

Neurological examination: patient with a GCS of 14 confused with incoherent speech at times, non-aggressive and agitated at times. no meningeal stiffness, having presented myoclonus of the right hemibody with a spasm of the left hemiface with reduced muscular strength of the left hemibody but osteotendinous reflexes still present but reduced on the left side.

Brain MRI instead of a CT scan (to avoid a worsening of tubular necrosis) was carried out showing the presence of a right temporo-occipital cortical hypersignal as well as the posterior part of the thalamus (pulvinar Sign) which flashes in diffusion in favor of a status epilepticus

*Presence of a rounded hypointense lesion on T2* which may be related to a cavernoma (which could be the cause of its cortical irritation)

Thus, the patient was immediately admitted to the A4 intensive care unit

• Patient initially treated as status epilepticus on Gardenal loading dose and maintenance then put on Lamictal 25mg: 1 tab/day for 2 weeks, then 1 tab*2/day for 2 weeks, then 2 tabs in the morning and 1 tab in the evening for 2 weeks then lamictal 50mg: 1 tab*2/d

• Urbanyl 10mg: 1 tab*3/d for 7 days then 1-1/2-1 for 7 days then 1-0-1 for 7 days then 1/2-0-1 for 7 days then 1/2-0 -1/2 for 7d then 0-0-1/2 pdt 7d then stop 

Psychiatric examination: finds a stable patient on the psychomotor level, disoriented in time and space, familiar contact, playfulness continuous court speech at normal pace with multiple responses alongside, ideas of overestimation and grandeur, no delirium detected during this examination the patient denies perceptual disturbances insight.

CAT: An organic origin was implicated given the patient’s picture and the patient was put on risperidone 1 mg in the evening + valium 10 mg 3 times a day 

The biological assessment showed

• On the hematological level: Hb 15 PLQ 267000 TP correct TCA iso GB 18750 CRP 115

• Rhabdomyolysis assessment: CPK 2733 CPKMB 61

• Liver function: ASAT 52 ALAT 27 GGT 27 PAL 108

• Kidney function: Urea 1.44 Creatinine 18

• Drug assessment (Toxicology): returned in favor THC + Barbiturates positive in urine

A measurement of arterial blood gases showed a pH of 7.23, alkaline reserves of 12mmol/L, pCO2 of 35 mmHg, PaO2 of 115 mmHg and lactate level of 2.79 mmol/L Na 135 K 4.8 Hb 12

EVOLUTION

During the rest of his stay: Patient remained stable on the hemodynamic and respiratory level, calm GCS 14 but still confused, afebrile with an improving inflammatory assessment.

Therapeutically: Rehydration, Basic ration, thromboprophylaxis, gastric protection, lamictal, urbanyl, valium, Augmentin.

In total, this is a patient, 64 years old with psychosis with poor therapeutic compliance admitted to the A4 Multipurpose Intensive Care Department of the HASSAN II University Hospital in Fez, in a case of cade oil intoxication in whom the evolution was marked by a clinical-biological improvement, the patient was discharged and transferred to the Psychiatry department for further treatment.

DISCUSSION

Cade oil intoxication causes cardiovascular, neurological, renal and respiratory problems. Phenol remains the most toxic component and probably responsible for the majority of systemic symptoms observed during poisoning. Its absorption is rapid, its metabolism is essentially hepatic. Its renal and hepatic toxicity is well known [8]. Systemic toxicity is multivisceral and could be explained by the formation of cytotoxic metabolites. The hydroxylation of phenols produces semiquinone radicals whose oxidation leads to the formation of toxic free radicals when the quantity ingested exceeds the hepatic conjugation capacities [9].

According to Christiansen and Klaman et al. [10], cardiac, renal and hepatic toxicities are well known [11,12] following phenol toxicity. Hashimoto et al. [13], observed elevations in aminotransferases (AST 10,450 IU/L, ALT 8,990 IU/L), LDH (15,580 IU/L) and CK (170 IU/L) after 24 h of ingestion of approximately 70 mL of a 50% solution of cresol, in a 26-year-old woman who was initially asymptomatic.

An alteration of the central and peripheral nervous system such as involuntary movements, headache, hypotonia, mental confusion and then myoclonic or convulsive coma has been reported in several cases of phenol poisoning [14-16].

Hepatic cytolysis by centrilobular necrosis, which is linked to the formation of semi-quinone radicals, has been observed in several cases of phenol poisoning [13]. Renal tubular necrosis is due to both direct cytotoxicity, hemodynamic disorders and the precipitation of hemoglobin and myoglobins in the tubules.

Wu et al. [13], reported that acute renal failure (urea 49 mg/ dL, creatinine 9.8 mg/dL), mild gastrointestinal toxicity and pneumonia occurred following intentional ingestion of 150 g of cresol in a 44 year old man.

Koruk et al., reported acute renal failure (urea = 1.14 g/L, serum creatinine = 4.7 mg/dL) in a subject who took one tablespoon of cade oil to treat nephrolithiasis [14]. Multi-visceral damage is accompanied by metabolic acidosis and sometimes, consumption coagulopathy [16]. Lung damage can range from pneumonia to acute lung edema and can appear when applied to the skin or taken orally.

Toxic doses of phenol cause initial hypertension, followed by a marked drop in blood pressure. This is mainly due to depression of the central vasomotor system leading to a loss of vasoconstrictor tone, but also to a reduction in cardiac output secondary to a direct effect of phenol on the myocardium [17].

Christiansen and Klaman et al. [10], reported that hypotension can progress to cardiovascular shock.

Juniperus oxycedrus contains ethereal oils, a tripene (cadinene resin) and phenols (guaiacol and cresol derivatives). Phenol causes severe hypotension, hypothermia, tachypnea, and tachycardia [18-20].

On a biological level, the elevation of muscle enzymes is often significant, it is due to caustic digestive lesions, clonic movements and direct cytotoxicity. Treatment requires early emergency care and often in an intensive care unit.

CONCLUSION

Juniperus oxycedrus contains phenol which has potentially fatal effects: corrosive, cardiac, neurological, hemolytic, pulmonary and renal. Hence the interest in mentioning it when faced with any picture of multi-visceral failure.

REFERENCES

1. Daly FF, Fountain JS, Murray L, Graudins A and Buckley NA. Guidelines for the management of paracetamol poisoning in Australia and New Zealand explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust. 2008; 188: 296-301.

2. Dart RC, Erdman AR, Olson KR, Christianson G, Manoguerra AS, Chyka PA,et al. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2006; 44: 1-18.

3. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics. 1975; 55: 871-876.

4. Baytop T. Türkiye’de bitkiler ile tedavi geçmiste ve bugün. Istanbul Universitesi Yay?nlar? yay?n no 3255. Ecz Fak.No: 40, sayfa 203, Istanbul, Türkiye, 1984.

5. JC. Amoric Skin absorption and toxic accidents of local treatments in children. Rev Fr Allergol Immunol Clin. 2000.

6. Hamba A. Cadier and cade oil (Juniperus oxycedrus L. and Pix Cadi). (PhD Thesis in Pharmacy). Montpellier.

7. Koruk ST, Ozyilkan E, Kaya P, Colak D, Donderici O, Cesretli Y. Juniper tar poisoning. Clin Toxicol (Phila). 2005; 43: 47-49.

8. Skalli S, Chebat A, Badrane N, Ben Cheikh R. Sideeffects of cade oil in Morocco: an analysis of reports in theMoroccan herbal products database from 2004 to 2012. Food Chem Toxicol 2014; 64: 81-85.

9. Bismuth C, Baud F, Garnier R. Clinical toxicology. Paris: Flam-marion; 2000.

10. Poison Control Center, Refik Saydam H?fz?ss?hha Hygiene Institute, Ankara, Turkey.

11. Pohanish RP. Sittig’s Handbook of Toxic and Hazardous Chemicals and Carcinogens. 6th ed. NY: Noyes Publications/William Andrew Publishing, Norwich. 2002.

12. ITI: Toxic and Hazardous Industrial Chemicals Safety Manual. Tokyo, Japan: The International Technical Information Institute, 1995.

13. Hathaway GJ, Proctor NH, Hughes JP, et al. Chemical Hazards of the Workplace. 4th ed. New York, NY: Van Nostrand Reinhold Company, 1996.

14. Sakai Y, Abo W, Yagita K, T Tanaka, T Doi, C Fuke. Chemical burn with systemic cresol intoxication. Pediatr Int 1999; 41: 174-176.

15. ACGIH. Documentation of threshold limit values and biological exposure indices. In: American Conference of Government of Industrial Hygienists Inc. 7th ed. Cincinnati OH. 2001.

16. Gleason MN, Gosselin RE, Hodge HC, editors. Clinical toxicology of commercial products. 2nd ed. Baltimore: Williams and Wilkins; 1963; 189.

17. Gieger TL, Correa SS, Taboada J, Grooters M, Johnson AJ. Phenol poisoning in three dogs. J Am Anim Hosp Assoc. 2000; 36: 317-321.

18. Esin Ozyilkan, P?nar Kaya, Dilsen Colak, Omer Donderici. Department of Internal Medicine, Ankara Training and Education Hospital, Ankara, Turkey Y?ld?r?m Cesaretli.

19. https://santejeunes.ma/intoxication-a-lhuile-de-cade-katrane/

20. www.capm.ma

Mugisha A, Salaheddine S, Naoufil H, Nabil K (2024) Childhood Poisoning with Juniperus oxycedrus (Cade Oil): About a Case at the A4 Intensive Care Unit of the HASSAN II University Hospital in Fez. JSM Clin Case Rep 12(2): 1240.

Received : 02 May 2024
Accepted : 30 Jun 2024
Published : 30 Jun 2024
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X